
Clinical Apllication
Testing aldosterone is used to diagnose the primary hyperaldosteronism (Conn’s syndrome) and secondary hyperaldosteronism Testing aldosterone is used to determine the cause of hypoaldosteronism, with a low aldosterone response indicating a primary hypoaldosteronism of the adrenals, while a large response indicating a secondary hypoaldosteronism.
The angiotensin II has its established to monitor of hypertension.
The angiotensin II has its established to monitor of hypertension.
Assay Characteristics
ALD | A I | A II | |
---|---|---|---|
Principle | competitive Chemiluminescence Immunoassay (CLIA) | ||
Sample Type | Serum, plasma and treated urine | Plasma | Plasma |
Sample volume | 100 μL | 100 μL | 100 μL |
Limit of Detection | 8.0 pg/mL | 0.15 ng/mL | 7.5 pg/mL |
Measuring range | 5.0-2000 pg/mL | 0.1-24 ng/mL | 5.0-1000 pg/mL |
Precision | 3.21-6.90% (29.94-998.97 pg/mL) | 4.46-7.44% (0.70-7.98 ng/mL) | 3.60-7.48% (25.39-249.70 pg/mL) |
Assay Characteristics
A comparison of commercially available ALD with Snibe MAGLUMI® ALD using clinical samples gave the following correlations (μg/mL):
Y = 1.011 X – 0.917 r2=0.994
n = 100